Class IITerminatedD-0422-2024
Drug recall · April 3, 2024
Sodium Citrate 4% 3 mL recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sodium Citrate 4% 3 mL, Anticoagulation Solution Injection (Concentration = 40/mg/mL) 3mL fill Syringe, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0900-25, Bar Code 70004090025
- Lots / codes
Lot #: 1223048444 Exp 11/20/23; 1223049011 Exp 12/12/23; 1223049673 Exp 01/09/24; 1223049771 Exp 01/12/24
- Quantity
- 9,624 syringes
- Company
- SCA Pharmaceuticals, LLC, Windsor, CT
- Distribution
- Nationwide in the USA
- Initiated
- November 9, 2023 · Voluntary: Firm initiated
- Classified
- March 22, 2024
- Reported
- April 3, 2024
- Ended
- August 27, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedApr 3, 2024Diltiazem HCl 125 mg in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals, LLC · D-0394-2024Class IITerminatedApr 3, 2024fentaNYL 2SCA Pharmaceuticals, LLC · D-0395-2024Class IITerminatedApr 3, 2024fentaNYL 2SCA Pharmaceuticals, LLC · D-0396-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLSCA Pharmaceuticals, LLC · D-0397-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLSCA Pharmaceuticals, LLC · D-0398-2024Class IITerminatedApr 3, 2024fentaNYL 100 mcg/50 mLSCA Pharmaceuticals, LLC · D-0399-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLSCA Pharmaceuticals, LLC · D-0400-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLSCA Pharmaceuticals, LLC · D-0401-2024Class IITerminatedApr 3, 2024fentaNYL 1SCA Pharmaceuticals, LLC · D-0402-2024Class IITerminatedApr 3, 2024fentaNYL 2SCA Pharmaceuticals, LLC · D-0403-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 20 mg/100mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals, LLC · D-0404-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals, LLC · D-0405-2024
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.